Exchange: OTC·Updated 01:04 PM EDT

INFIQ Infinity Pharmaceuticals Inc.

$0.00
$0.00
(0.00%)
Today
Reported EarningsMar 28
Mkt Cap$91.00
Vol2,428.00

About INFIQ

Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.
60

Bullish Sentiment

How do you feel about INFIQ?

Advertisement|Remove ads.